BlackLine Announces Participation in Upcoming Investor Conference
BlackLine Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains BlackLine(BL.US) With Buy Rating, Raises Target Price to $86
Genpact Renews Collaboration With Ferring Pharmaceuticals
A Quick Look at Today's Ratings for BlackLine(BL.US), With a Forecast Between $60 to $80
BlackLine's Strategic Shift and Innovative Approach Drive Buy Recommendation
Morgan Stanley Maintains BlackLine(BL.US) With Buy Rating, Maintains Target Price $80
BofA Securities Maintains BlackLine(BL.US) With Sell Rating, Raises Target Price to $50
William Blair Maintains BlackLine(BL.US) With Hold Rating
Cautious Optimism: Assessing BlackLine's Growth Potential Amid Uncertainties
Piper Sandler Maintains Neutral on BlackLine, Maintains $60 Price Target
BlackLine Launches Studio360 Platform to Drive Future-Ready Financial Operations for the Office of the CFO
Express News | Blackline Inc - Repurchases to Begin Q1 2025
Express News | Blackline Inc - on Nov 17, Board Authorized $200 Million Stock Repurchase of Co's Common Stock
BlackLine Recognized as Most Innovative FinTech Solution by the 2024 Tech Ascension Awards
What Does BlackLine, Inc.'s (NASDAQ:BL) Share Price Indicate?
Private Companies Own 26% of Blackline Safety Corp. (TSE:BLN) Shares but Individual Investors Control 45% of the Company
We Think That There Are Issues Underlying BlackLine's (NASDAQ:BL) Earnings
Expert Outlook: BlackLine Through The Eyes Of 6 Analysts
BlackLine Is Maintained at Overweight by Morgan Stanley